A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.
Study ID: 5808
NCT Number: NCT06456580
Principal Investigator: W. David Arnold, MD
Department: Health Affairs
Eligibility: Both men and women 18 years old to 99 years old. Does not accept healthy volunteers.
For questions about this study, please contact:
ClinicalTrialsInterest@health.missouri.edu(573) 882-7026